Sugar (sucrose) and fatty acid compounds with triglycerides on the treatment of wounds: experimental study in rats.

BACKGROUND: In the last 10 years, the use of essential fatty acids (EFA) compounds for the treatment of wounds has increased in Brazil, while there has been reducing indication for the use of sugar. OBJECTIVE: The aim of this study was to evaluate the response to saline, sugar and EFA on induced wounds in rats. METHODS: A wound of 400 mm(2) was produced on the back of each Wistar rat. The rats were divided into three groups, each being treated with either saline, sugar or EFA. All the animals received a closed dressing on the wounds, changed daily. Measures were taken in four moments, and the values of wound area reduction by healing, cellular inflammatory response, collagen ordering and types I and III collagen density were assessed. RESULTS: The wound healing was equal in all the three groups, but sugar promoted an inflammatory response modulation between the 7th and 14th days. On the 20th post-operative day, there were no differences between the three treated groups concerning types I and III collagen. CONCLUSIONS: The wounds healed in the three groups. The sugar group promoted effective cellular inflammatory response modulation. There were no differences between all the treated groups regarding types I and III collagen at the end of this study.

Açúcar (sacarose) e triglicerídeos de cadeia média com ácidos graxos essenciais no tratamento de feridas cutâneas: estudo experimental em ratos / Sugar (sucrose) and fatty acid compounds with triglycerides on the treatment of wounds: experimental study in rats

FUNDAMENTOS: Na última década, as indicações de uso tópico de compostos com ácidos graxos essenciais (AGE-TG) para o tratamento de feridas aumentaram no Brasil, e houve declínio das indicações do açúcar. OBJETIVOS: Estudar o efeito da aplicação de solução fisiológica de cloreto de sódio a 0,9 por cento, de açúcar e de AGE-TG sobre feridas experimentalmente induzidas em ratos. MÉTODOS: Foi induzida uma ferida de 400 mm2 no dorso de cada rato Wistar, constituindo três grupos tratados separadamente com solução fisiológica de cloreto de sódio a 0,9 por cento, açúcar e AGE-TG. Todos os animais receberam curativo oclusivo sobre a lesão, trocado a cada 24 horas. As aferições realizadas em quatro momentos consistiram na determinação do percentual de redução das áreas das feridas, da reação inflamatória celular, da ordenação do colágeno e da densidade de colágeno dos tipos I e III nas cicatrizes. RESULTADOS: A cicatrização ocorreu igualmente nos grupos estudados, mas o açúcar modulou positivamente a reação inflamatória entre o 7º e 14º dias. No 20º dia, não houve diferenças na quantidade de colágeno dos tipos I e III entre os grupos tratados. CONCLUSÕES: As feridas cicatrizaram nos três grupos. O grupo açúcar apresentou uma modulação positiva da resposta inflamatória celular. Não houve diferenças na quantidade de colágeno dos tipos I e III ao final do experimento nos grupos tratados.

BACKGROUND: In the last 10 years, the use of essential fatty acids (EFA) compounds for the treatment of wounds has increased in Brazil, while there has been reducing indication for the use of sugar. OBJECTIVE: The aim of this study was to evaluate the response to saline, sugar and EFA on induced wounds in rats. METHODS: A wound of 400 mm2 was produced on the back of each Wistar rat. The rats were divided into three groups, each being treated with either saline, sugar or EFA. All the animals received a closed dressing on the wounds, changed daily. Measures were taken in four moments, and the values of wound area reduction by healing, cellular inflammatory response, collagen ordering and types I and III collagen density were assessed. RESULTS: The wound healing was equal in all the three groups, but sugar promoted an inflammatory response modulation between the 7th and 14th days. On the 20th post-operative day, there were no differences between the three treated groups concerning types I and III collagen. CONCLUSIONS: The wounds healed in the three groups. The sugar group promoted effective cellular inflammatory response modulation. There were no differences between all the treated groups regarding types I and III collagen at the end of this study.

Termocoagulação endoscópica do esôfago de Barrett com plasma de argônio sob diferentes potências: análise histopatológica e de sintomas pós-procedimento / Endoscopic argon plasm thermo-coagulation of Barrett's esophagus using different powers: histopathological and post procedure symptons analysis

Objetivo: Definir qual a melhor potência a ser empregada de forma a atingir a profundidade necessária para ablação com o menor número de sintomas pós-procedimento. Método: Foram estudados 28 pacientes com esôfago de Barrett, após tratamento cirúrgico do refluxo ou em uso de bloqueadores de bomba de prótons, submetidos à ablação endoscópica, randomizados em dois grupos com potências diferentes - 50 ou 70W. Imediatamente após, foram realizadas biópsias endoscópicas das áreas fulguradas. A sintomatologia foi avaliada por questionário telefônico. Resultados: Não houve diferença entre os grupos quanto a idade, a extensão do esôfago de Barrett, a porcentagem da circunferência esofagiana coagulada e a duração dos sintomas. A dor foi o sintoma predominante e a disfagia ocorreu de forma transitória. Houve correlação negativa moderada entre número de sintomas e potência (potência mais baixa com maior número de sintomas), porém sem diferença significativa. Em 40% dos casos em que se utilizou menor potência obteve-se fragmentos que atingiram apenas a porção superficial da mucosa, o que só ocorreu em 10% dos casos no grupo de 70W. Não foi observada diferença significativa entre a potência utilizada ou o acometimento da muscular da mucosa e o número de sintomas. Conclusões: A utilização de potência de 70W durante a coagulação do esôfago de Barrett com plasma de argônio sugere associação com menor incidência de metaplasia colunar especializada residual abaixo do epitélio escamosoneoformado.

Objective: To establish the ideal power to be employed in order to get the effective ablation and the lowest rate of symptoms at argon plasma thermocoagulation in Barrett’s esophagus (BE). Methods: Twenty-eight asymptomatic patients with BE, wererandomly divided in two groups of different ablation powers, 50W or 70W. After endoscopic ablation and biopsies from the treated area for histological analyses, symptoms were evaluated through a questionnaire answered by phone. Results: Thirteen patients without specialized columnar metaplasia were excluded and the remaining fifteen patients, seven men (46,7%) and eight women (53,3%), with an average age of 53 years +10,4, composed the two groups: 10 patients at the 70W power and 5 at the 50W power group. There was no significant difference between the groups regarding age, BE extent, percentage of coagulated esophagealcircumference and the duration of symptoms. Pain was the most important symptom, with a mean duration of 10,3 + 9,7 days. When power was compared to symptoms, although not statistically significant, a moderate negative correlation was noted. Endoscopic biopsies showed ablation restricted to the mucosa’s superficial layer in 40% of the cases in the lower power group, andonly 10% in the higher power group, although deeper layers of the mucosa were compromised. There were no statistical significant differences when comparing the different powers to the penetration through the mucosa’s layers and the symptoms. Conclusion: There are evidences that the 70W potency argon plasma coagulation for BE leads to a lower incidence of residual specializedcolumnar metaplasia under the new scamous epithelium.

[Endoscopic argon plasma thermo-coagulation of Barrett's esophagus using different powers: histopathological and post procedure symptons analysis]. / Termocoagulação endoscópica do esôfago de Barrett com plasma de argônio sob diferentes potências: análise histopatológica e de sintomas pós-procedimento.

OBJECTIVE: To establish the ideal power to be employed in order to get the effective ablation and the lowest rate of symptoms at argon plasma thermocoagulation in Barrett's esophagus (BE). METHODS: Twenty-eight asymptomatic patients with BE, were randomly divided in two groups of different ablation powers, 50W or 70W. After endoscopic ablation and biopsies from the treated area for histological analyses, symptoms were evaluated through a questionnaire answered by phone. RESULTS: Thirteen patients without specialized columnar metaplasia were excluded and the remaining fifteen patients, seven men (46,7%) and eight women (53,3%), with an average age of 53 years +10,4, composed the two groups: 10 patients at the 70W power and 5 at the 50W power group. There was no significant difference between the groups regarding age, BE extent, percentage of coagulated esophageal circumference and the duration of symptoms. Pain was the most important symptom, with a mean duration of 10,3 + 9,7 days. When power was compared to symptoms, although not statistically significant, a moderate negative correlation was noted. Endoscopic biopsies showed ablation restricted to the mucosa's superficial layer in 40% of the cases in the lower power group, and only 10% in the higher power group, although deeper layers of the mucosa were compromised. There were no statistical significant differences when comparing the different powers to the penetration through the mucosa's layers and the symptoms. CONCLUSION: There are evidences that the 70W potency argon plasma coagulation for BE leads to a lower incidence of residual specialized columnar metaplasia under the new scamous epithelium.